Tuesday, October 24, 2023
09:30 am
- 09:40 am
EST
Welcoming Remarks
Eric Freed, Ph.D.
NCI-Frederick
09:40 am
- 10:15 am
EST
Cancer Immunotherapy with recombinant poliovirus
Matthias Gromeier, M.D.
Duke University School of Medicine
10:15 am
- 10:50 am
EST
CAR T-cell therapy for hematologic malignancies
Jennifer Brudno, M.D.
National Cancer Institute
10:50 am
- 11:25 am
EST
AAV-vectored expression of monoclonal antibodies for protection against infectious diseases
Sarah Wootton, BSc, Ph.D.
Ontario Veterinary College
11:25 am
- 12:00 pm
EST
Tuning antiviral immunity with gene-based vectors
Nancy Sullivan, ScD.
Boston University
12:00 pm
- 01:20 pm
EST
Lunch/Poster Session
01:20 pm
- 01:55 pm
EST
In vivo affinity maturation of engineered B cells for better vaccines and anti-viral antibodies
Michael Farzan, Ph.D.
Harvard University
01:55 pm
- 02:30 pm
EST
The unique immune biology of cytomegalovirus-based vaccines
Klaus Fruh, Ph.D.
Oregon Health and Sciences University
02:30 pm
- 03:05 pm
EST
Phage Therapy
Robert "Chip" Schooley, M.D.
UC San Diego
03:05 pm
- 03:45 pm
EST
Break/Poster Session
03:45 pm
- 04:20 pm
EST
The enemy within: Turning transposons from foes to friends
David Largaespada, Ph.D.
University of Minnesota
04:20 pm
- 04:55 pm
EST
Virus vs virus: Human endogenous retroviruses as antiviral restriction factors
John Coffin, Ph.D.
Tufts University
04:55 pm
- 05:05 pm
EST
Closing Remarks
Eric Freed, Ph.D.
NCI-Frederick